QuantLogix ← BAX scorecard
📅 BAX Earnings Preview
Baxter International Inc.
Next report (est.)
10/27/2026
Countdown
Imminent
EPS growth YoY
+33.3%
Revenue growth YoY
+5.3%
Options-implied earnings move
±7.2%
The at-the-money straddle prices a move to roughly $27.11 or $23.46 from $25.29 by 10/30/2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
07/30/2026 ±3.6% +8.0% under-priced
04/30/2026 ±4.0% +4.0% under-priced
02/12/2026 ±3.2% -16.0% under-priced
11/04/2025 ±6.8% -1.5% over-priced
08/05/2025 ±9.2% +1.8% over-priced
05/06/2025 ±3.7% -1.6% over-priced
02/21/2025 ±3.1% +1.1% over-priced
11/12/2024 ±3.7% -1.1% over-priced
Across these reports, options implied an average ±4.7% move vs an actual average of 4.4% — the stock stayed inside the implied band 63% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $0.24 $3.0B $126M
Q1 FY2026 $-0.03 $2.7B $-15M
Q4 FY2025 — $3.0B $-1.1B
Q3 FY2025 $-0.09 $2.8B $-46M
Analyst posture
Buy / Strong Buy
5
Hold
14
Sell
0
Strong upward revisions — 6 net (vs 5 prior)
Live 5-factor engine read: Buy · 67/100 Full scorecard →
🤖 Pro runs a 10-agent AI debate on BAX before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Baxter International Inc. (BAX) reports imminently, with the next report estimated for 10/27/2026. Across the last 8 reports, options priced an average ±4.7% earnings move while the stock actually moved 4.4% on average — the market has been roughly fair on BAX's earnings risk. Fundamentals into the print: EPS up 33.3% year-over-year, revenue up 5.3%. QuantLogix's live 5-factor engine currently reads BAX as a buy at 67/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →